Surgery Clinical Trial
Official title:
Pain Relief in Laparoscopic Surgery - to Relief Pain After Laparoscopic Surgery With the Use of a Altered Gas
Verified date | March 2022 |
Source | Jessa Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pain relief after laparoscopic surgery with the use of an altered gas.
Status | Completed |
Enrollment | 74 |
Est. completion date | February 17, 2022 |
Est. primary completion date | February 17, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Woman = 18 years old - undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy. Exclusion Criteria: - Women < 18 years old - Males - Pregnancy - Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease. - Conditions causing acute pain e.g. abdominal trauma |
Country | Name | City | State |
---|---|---|---|
Belgium | Jessa Hospital | Hasselt | Limburg |
Lead Sponsor | Collaborator |
---|---|
Jessa Hospital |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of post-operative pain with an 11-point numerical rating score (NRS) | Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain | 4 hours after laparoscopic surgery | |
Secondary | Assessment of post-operative pain (NRS) | Assessement of pain at different time points after surgery with an 11-point numerical rating score NRS, where 0 means no pain and 10 means worst imaginable pain | 8 hours, 24 hours and 7 days after laparoscopic surgery | |
Secondary | Nausea | Assessment of nausea at different time points after surgery (yes/no) | 4 hours, 8 hours, 24 hours and 7 days after laparoscopic surgery | |
Secondary | Post-operative use of piritramide (Dipidolor®) | Dose of piritramide after laparoscopic surgery in patients treated with altered gas compared to patients treated with the standard gas | Up to 24 hours after laparoscopic surgery | |
Secondary | Assessment of degree of a possible inflammatory reaction | Assessed via standard medical practice: body temperature will be measured in °C in order to investigate fever | Through study completion, up to 7 days after laparoscopic surgery | |
Secondary | Assessment of degree of a possible inflammatory reaction | Assessed via standard medical practice: potential blood samples measuring C-Reactive Protein (in mg/l) which is a measure for inflammation can be measured if needed throughout the study | Through study completion, up to 7 days after laparoscopic surgery | |
Secondary | Time to resumption of transit | Time to first flatus and time to first stool | Through study completion, up to 7 days after laparoscopic surgery | |
Secondary | Assessment of quality of Recovery (QOR) | Assessment of QOR using the 1-item Global Surgical Recovery (GSR) index which represents a single question about the extent to which patients considered themselves to be recovered from surgery ("if 100% recovery means the participants health is back to the same level as it was before the surgery, what percentage of recovery is the participant at now") | 24 hours and 7 days after laparoscopic surgery | |
Secondary | Assessment of quality of Recovery (QOR) | Assessment of QOR using the Functional Recovery Index (FRI) questionnaire which assesses functional QOL on an NRS scale and covers 14 items grouped under three factors (pain and social activity, lower limb activity and general physical activity) | 24 hours and 7 days after laparoscopic surgery | |
Secondary | Patient satisfaction | Assessement of patient satisfaction via a seven-point Likert scale, where 1 means extremely unsatisfied and 7 means extremely satisfied | 7 days after laparoscopic surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT06397287 -
PROM Project Urology
|
||
Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |